Systematic multiomics analysis and in vitro experiments suggest that ITGA5 could serve as a promising therapeutic target for ccRCC.

Autor: Che, Xiangxian^1,2 (AUTHOR), Tian, Xi^1,2,3 (AUTHOR), Wang, Zhenda^1,2,3 (AUTHOR), Zhu, Shuxuan^1,2,3 (AUTHOR), Ye, Shiqi^1,2,3 (AUTHOR), Wang, Yue^1,2,3 (AUTHOR), Chen, Yihan² (AUTHOR), Huang, Yiyun² (AUTHOR), Anwaier, Aihetaimujiang^1,2,3 (AUTHOR), Yao, Peifeng⁴ (AUTHOR), Chen, Yijia² (AUTHOR), Wu, Keting² (AUTHOR), Liu, Yifei² (AUTHOR), Xu, Wenhao^1,2,3 (AUTHOR) xwhao0407@163.com, Zhang, Hailiang^1,2,3 (AUTHOR) zhanghl918@163.com, Ye, Dingwei^1,2,3 (AUTHOR) dwyelie@163.com

Publikováno v: Cancer Cell International. 11/5/2024, Vol. 24 Issue 1, p1-18. 18p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.